Lundorff P, Hahlin M, Sjöblom P, Lindblom B
Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Göteborg, Sweden.
Obstet Gynecol. 1991 Jan;77(1):129-33.
The incidence of persistent trophoblast and risk of second surgical intervention after conservative treatment of tubal pregnancy are substantial. The preoperative and postoperative hCG patterns in patients with tubal pregnancy were studied to see whether this information could predict and detect persistent trophoblast at an early stage. Ninety-eight women with tubal pregnancy underwent conservative surgical treatment by laparoscopy or laparotomy. Eight developed postoperative complications necessitating a second operation, and seven of them had both biochemical and histologic evidence of persistent trophoblastic activity. In seven of 31 patients with preoperative hCG above 3000 IU/L, a second operation was necessary, whereas in 67 with preoperative hCG levels below 3000 IU/L, only one such intervention was necessary. Eight of the 22 patients with hCG above 1000 IU/L on the second day after surgery and seven of 11 patients with hCG above 1000 IU/L on the seventh day after surgery later needed a second surgical procedure. In contrast, 86 of 87 women with hCG below 1000 IU/L on the seventh day after surgery had an uneventful convalescence. We conclude that pre- and postoperative hCG measurements can identify patients at risk of developing persistent trophoblast. Further, in patients with preoperative hCG titers below 3000 IU/L, we recommend conservative surgery followed by measurement of hCG 1 week postoperatively.
输卵管妊娠保守治疗后持续性滋养细胞的发生率及二次手术干预的风险较高。对输卵管妊娠患者术前及术后的人绒毛膜促性腺激素(hCG)模式进行了研究,以确定该信息是否能在早期预测和检测持续性滋养细胞。98例输卵管妊娠妇女接受了腹腔镜或剖腹保守手术治疗。8例出现术后并发症需要二次手术,其中7例有持续性滋养细胞活性的生化和组织学证据。术前hCG高于3000 IU/L的31例患者中有7例需要二次手术,而术前hCG水平低于3000 IU/L的67例患者中仅1例需要此类干预。术后第二天hCG高于1000 IU/L的22例患者中有8例,术后第七天hCG高于1000 IU/L的11例患者中有7例后来需要二次手术。相比之下,术后第七天hCG低于1000 IU/L的87例妇女中有86例恢复顺利。我们得出结论,术前和术后hCG测量可以识别有发生持续性滋养细胞风险的患者。此外,对于术前hCG滴度低于3000 IU/L的患者,我们建议进行保守手术后在术后1周测量hCG。